secwatch.observer — SEC 8-K summary
======================================

Issuer:     Twist Bioscience Corp (TWST)
CIK:        0001581280
Form:       8-K
Filed at:   2022-11-16T23:59:59+00:00
Accession:  0001104659-22-119241
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Twist Bioscience refutes Scorpion Capital short-seller report as misleading; Q4 results Nov 18
--------------------------------------------------------------------------------

- Twist calls Scorpion Capital report 'highly misleading' with many distortions and inaccuracies.
- Reaffirms commitment to truthful communication, ESG practices, and shipping from Factory of the Future in Jan 2023.
- Will report fiscal Q4 and full-year 2022 results on Nov 18, 2022 before market open; conference call at 8am ET.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1581280/000110465922119241/0001104659-22-119241-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1581280/000110465922119241/tm2230663d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-119241

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer